Acute coronary syndromes

Original title: Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from...

solaci - 7 May, 2014

Infusion of bone marrow mononuclear cells in acute myocardial infarction, meta-analysis of all published to date.

Original title: Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials. Reference: de Jong...

solaci - 12 April, 2014

Acute coronary syndromes

Deferred Stenting in Primary Angioplasty could reduce No Reflow Risk and Infarct Size.

Original: A Randomized Trial of Deferred Stenting versus Immediate Stenting to Prevent No-or Slow Reflow in Acute ST-Elevation...

solaci - 17 March, 2014

Acute coronary syndromes

Multivessel angioplasty in acute myocardial infarction improves prognosis

Original title: Acute multivessel revascularization improves 1 year outcomes in ST-elevation myocardial infarction. A nationwide study from AMIS...

solaci - 7 March, 2014

Acute coronary syndromes

Almost 40 % of those who initially receive clopidogrel then switch to prasugrel or ticagrelor in clinical practice.

Original title: In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary...

solaci - 7 February, 2014

Acute coronary syndromes

The radial access is a viable alternative in infarction complicated with cardiogenic shock

Severe coronary calcification is a predictor of coronary events in acute coronary syndromes

Blush reduction in a not responsible vessel is a prognostic marker in those receiving angioplasty in the culprit vessel.

Higher event rate in those with non-ST elevation ACS who received revascularization at PLATO study. Beyond this, ticagrelor reduced mortality.

Infusion of bone marrow mononuclear cells in acute myocardial infarction, meta-analysis of all published to date.

Deferred Stenting in Primary Angioplasty could reduce No Reflow Risk and Infarct Size.

Multivessel angioplasty in acute myocardial infarction improves prognosis

Almost 40 % of those who initially receive clopidogrel then switch to prasugrel or ticagrelor in clinical practice.

Últimas Noticias

Long-Term Cardiovascular Risk in Patients With ANOCA: A Clinical Reality to Consider?

Perforation Management in Bifurcations: Bench Testing of Bailout with Covered Stents

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Noticias Institucionales

SOLACI Wishes You Happy Holidays

Condolences on the passing of Cristiam Arancibia

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Accesos